PAIN
Volume 146, Issue 3 , Pages 253-260 , 5 December 2009

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

  • Amy S. Chappell

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 317 277 3846; fax: +1 317 276 6026.
    • ,
  • Melissa J. Ossanna

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN, USA
    • ,
  • Hong Liu-Seifert

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN, USA
    • ,
  • Smriti Iyengar

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN, USA
    • ,
  • Vladimir Skljarevski

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN, USA
    • ,
  • Linda Chunhong Li

      Affiliations

    • i3 Statprobe, Ann Arbor, MI, USA
    • ,
  • Robert M. Bennett

      Affiliations

    • Oregon Health & Science University, Portland, OR, USA
    • ,
  • Harry Collins

      Affiliations

    • Anderson & Collins Clinical Research, Inc., Edison, NJ, USA

Received 11 June 2008 ,Revised 1 June 2009 ,Accepted 18 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(09)00369-8

doi: 10.1016/j.pain.2009.06.024

PAIN
Volume 146, Issue 3 , Pages 253-260 , 5 December 2009

Article Tools

* Image Usage & Resolution